SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-17-038439
Filing Date
2017-06-09
Accepted
2017-06-09 16:33:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 8-K a17-14996_28k.htm 425 23530
2 EX-99.1 a17-14996_2ex99d1.htm EX-99.1 14901
3 GRAPHIC g149962mmi001.jpg GRAPHIC 3573
  Complete submission text file 0001104659-17-038439.txt   44960
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filed by) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37558 | Film No.: 17903366
SIC: 2834 Pharmaceutical Preparations